OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda
Patrick K. Tumwebaze, Melissa D. Conrad, Martin Okitwi, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Evolution of Partial Resistance to Artemisinins in Malaria Parasites in Uganda
Melissa D. Conrad, Victor Asua, Shreeya Garg, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 8, pp. 722-732
Open Access | Times Cited: 120

Antimalarial drug discovery: progress and approaches
Jair L. Siqueira-Neto, Kathryn J. Wicht, Kelly Chibale, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 10, pp. 807-826
Open Access | Times Cited: 93

Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa
Philip J. Rosenthal, Victor Asua, Melissa D. Conrad
Nature Reviews Microbiology (2024) Vol. 22, Iss. 6, pp. 373-384
Closed Access | Times Cited: 52

The emergence of artemisinin partial resistance in Africa: how do we respond?
Philip J. Rosenthal, Victor Asua, Jeffrey A. Bailey, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 9, pp. e591-e600
Open Access | Times Cited: 43

Urgent action is needed to confront artemisinin partial resistance in African malaria parasites
Deus S. Ishengoma, Roly Gosling, Rosario Martinez-Vega, et al.
Nature Medicine (2024) Vol. 30, Iss. 7, pp. 1807-1808
Closed Access | Times Cited: 11

High frequency of artemisinin partial resistance mutations in the great lake region revealed through rapid pooled deep sequencing
Neeva Wernsman Young, Pierre Gashema, David Giesbrecht, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 10

Combating antimicrobial resistance in malaria, HIV and tuberculosis
Maëlle Duffey, Robert W. Shafer, Juliano Timm, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 6, pp. 461-479
Closed Access | Times Cited: 9

Towards next-generation treatment options to combat Plasmodium falciparum malaria
John Okombo, David A. Fidock
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 9

High frequency of artemisinin partial resistance mutations in the Great Lakes region revealed through rapid pooled deep sequencing
Neeva Wernsman Young, Pierre Gashema, David Giesbrecht, et al.
The Journal of Infectious Diseases (2024)
Closed Access | Times Cited: 9

Changes in susceptibility of Plasmodium falciparum to antimalarial drugs in Uganda over time: 2019-2024
Martin Okitwi, Stephen Orena, Patrick K. Tumwebaze, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 1

Multiplexed ddPCR-amplicon sequencing reveals isolated Plasmodium falciparum populations amenable to local elimination in Zanzibar, Tanzania
Aurel Holzschuh, Anita Lerch, Inna Gerlovina, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 21

Treatment Failure in a UK Malaria Patient Harboring Genetically Variant Plasmodium falciparum From Uganda With Reduced In Vitro Susceptibility to Artemisinin and Lumefantrine
Donelly A. van Schalkwyk, Sade Pratt, Debbie Nolder, et al.
Clinical Infectious Diseases (2023) Vol. 78, Iss. 2, pp. 445-452
Open Access | Times Cited: 17

Limited threat of Plasmodium falciparum pfhrp2 and pfhrp3 gene deletion to the utility of HRP2-based malaria RDTs in Northern Uganda
Bosco Agaba, David J. Smith, Jye Travis, et al.
Malaria Journal (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8

Using a mobile nanopore sequencing lab for end-to-end genomic surveillance of Plasmodium falciparum: A feasibility study
Aurel Holzschuh, Anita Lerch, Bakar S. Fakih, et al.
PLOS Global Public Health (2024) Vol. 4, Iss. 2, pp. e0002743-e0002743
Open Access | Times Cited: 7

Aryl amino acetamides prevent Plasmodium falciparum ring development via targeting the lipid-transfer protein PfSTART1
Madeline G. Dans, Coralie Boulet, G. M. Watson, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7

Artemisinin Partial Resistance in Ugandan Children With Complicated Malaria
Ryan C. Henrici, Ruth Namazzi, Giselle Lima-Cooper, et al.
JAMA (2024)
Closed Access | Times Cited: 7

Indigenous emergence and spread of kelch13 C469Y artemisinin-resistant Plasmodium falciparum in Uganda
Phyllis Awor, Romain Coppée, Nimol Khim, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 8
Closed Access | Times Cited: 5

A review of efficacy and safety of Ugandan anti-malarial plants with application of RITAM score
Jimmy Ronald Angupale, Jonans Tusiimire, Ndidi C. Ngwuluka
Malaria Journal (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 11

Detection of Artemisinin Resistance Marker Kelch-13 469Y in Plasmodium falciparum, South Kivu, Democratic Republic of the Congo, 2022
Welmoed van Loon, Bertin C. Bisimwa, Valéry Byela, et al.
American Journal of Tropical Medicine and Hygiene (2024) Vol. 110, Iss. 4, pp. 653-655
Closed Access | Times Cited: 4

A Narrative Review on the Prevalence of Plasmodium falciparum Resistance Mutations to Antimalarial Drugs in Rwanda
Muharib Alruwaili, Abozer Y. Elderdery, Emad Manni, et al.
Tropical Medicine and Infectious Disease (2025) Vol. 10, Iss. 4, pp. 89-89
Open Access

Page 1 - Next Page

Scroll to top